Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abuse-deterring technology developer Egalet nets $53.9mm in IPO

Executive Summary

UK biotech Egalet Corp. netted $53.9mm in its US initial public offering. The company sold 4.8mm shares (including the overallotment; and more than the 3.5mm planned) at $12, the mid-point of its $11-13 price range.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies